Preview Mode Links will not work in preview mode

The Retina Channel Podcast


Mar 12, 2018

Dr. SriniVas Sadda discusses development of macular atrophy in an analysis of HARBOR Study which investigated treatment of wet AMD using 0.5 mg and 2.0 mg of Ranibizumab dosing. 

Full reference of the discussed article:

Sadda, S. R., Tuomi, L. L., Ding, B., Fung, A. E., & Hopkins, J. J. (2018). Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration. Ophthalmology. doi:10.1016/j.ophtha.2017.12.026